NASDAQ
Structure Therapeutics Inc. - American Depositary Shares (GPCR)
♥ 600 Thanks from members
Structure Therapeutics Inc. (GPCR) displays a polarized market sentiment around its oral GLP-1 asset aleniglipron, balancing strong Phase 3 clinical progression and solid cash reserves against surging cash burn, intense competition, and supply chain/legislative headwinds.